Related Experiment Video
Updated: Jan 17, 2026

19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
87.6K
Psychometric properties of the Infantile Neuroaxonal Dystrophy Rating Scale
Alessandra Girardi1, Linda Abetz-Webb2, Katja Rudell1
1Clinical Outcomes Assessment Science, Epidemiology and Real-World Evidence Science, Parexel International, London, UK.
Developmental Medicine and Child Neurology
|September 20, 2025
Summary
The Infantile Neuroaxonal Dystrophy Rating Scale (INAD-RS) demonstrates good reliability and validity for most domains in assessing infantile neuroaxonal dystrophy (INAD). Further refinement is needed for autonomic nervous system assessment in clinical trials.
Area of Science:
- Neurology
- Pediatric Neurology
- Clinical Assessment Tools
Background:
- Infantile Neuroaxonal Dystrophy (INAD) is a rare, progressive neurodegenerative disorder affecting young children.
- Standardized outcome measures are crucial for evaluating disease progression and treatment efficacy in INAD.
Purpose of the Study:
- To evaluate the psychometric properties of the Infantile Neuroaxonal Dystrophy Rating Scale (INAD-RS).
- To determine the reliability and validity of the INAD-RS for assessing patients with INAD.
Main Methods:
- Retrospective analysis of interim data from the INAD Natural History Study.
- Involved clinician ratings of 39 patients with INAD.
- Assessed internal consistency, test-retest reliability, known-group validity, and longitudinal changes.
Main Results:
- The INAD-RS demonstrated good internal consistency, convergent validity, and test-retest reliability for gross motor, fine motor, bulbar, ocular, and temporo-frontal functions.
- The autonomic nervous system domain showed weaker contribution.
- Preliminary evidence indicated the scale could differentiate clinical phenotypes and detect changes over time.
Conclusions:
- The INAD-RS exhibits construct validity and reliability across five of six domains, excluding autonomic nervous system function.
- The scale is a promising tool for INAD research and clinical practice.
- Further validation is required to support its use in clinical trials and practice for disease progression assessment.

